Stomach bacteria and fatty liver disease study
Part of Digestive system, Hormones & metabolism, Infections clinical trials.
This study looks for a possible link between a common stomach bacteria (Helicobacter pylori) and a type of fatty liver disease called MAFLD. It may help explain if treating the infection could improve liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with Metabolic Associated Fatty Liver Disease (MAFLD), confirmed by an ultrasound or other imaging.
- You are not pregnant.
- You do not have any active cancer.
- You do not have type 1 diabetes.
- You have not had weight-loss surgery, and you don't regularly drink alcohol or take certain medications (like steroids, acid reducers, antibiotics, or birth control pills).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a specific gut bacteria (Ruminococcus gnavus) and its byproducts are linked to fatty liver disease (MAFLD). It compares people with the condition to healthy individuals to better understand the connection.
This study looks at whether a common stomach infection called H. pylori is connected to health problems like high blood sugar, high blood pressure, and belly fat (metabolic syndrome). If you have stomach discomfort, you may be able to join and help researchers understand this link.
This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This study looks at people with fatty liver disease linked to metabolism. It checks if they also have fat in the pancreas.
This study looks at how stomach bacteria (Helicobacter pylori) interact with the normal microbes in your gut. You may be asked to provide tissue, stool, and blood samples to help researchers understand infection and the body’s response.
Hear when a new Helicobacter Pylori Infection Metabolic Dysfunction-Associated Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.